<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The phenotype of <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> osteoblasts differs from that of <z:mpath ids='MPATH_458'>normal</z:mpath> osteoblasts in the accumulation of macromolecules in the extracellular matrix </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> osteoblasts increase type I collagen, fibronectin and <z:chebi fb="0" ids="18085">glycosaminoglycans</z:chebi> secretion compared with <z:mpath ids='MPATH_458'>normal</z:mpath> osteoblasts </plain></SENT>
<SENT sid="2" pm="."><plain>Because the extracellular matrix <z:chebi fb="4" ids="33839">macromolecule</z:chebi> accumulation is greatly modulated by transforming growth factor-beta(1), we examined the ability of <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> osteoblasts to secrete transforming growth factor-beta(1) by <z:chebi fb="15" ids="3478">CCL</z:chebi>-64 assay and to produce transforming growth factor-beta(1 )by analysis of the <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of transforming growth factor-beta(1) </plain></SENT>
<SENT sid="3" pm="."><plain>Northern blot analysis revealed an increased amount of transforming growth factor-beta(1) <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> osteoblasts compared with <z:mpath ids='MPATH_458'>normal</z:mpath> ones </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, the level of the active transforming growth factor-beta(1) isoform was higher in <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> than in <z:mpath ids='MPATH_458'>normal</z:mpath> media </plain></SENT>
<SENT sid="5" pm="."><plain>In pathologic cells, the increase in transforming growth factor-beta(1) gene expression was associated with a parallel increase in the factor secreted into the medium </plain></SENT>
<SENT sid="6" pm="."><plain>The level of transforming growth factor-beta(1) was decreased by the addition of basic fibroblast growth factor </plain></SENT>
<SENT sid="7" pm="."><plain>Transforming growth factor-beta(1) is controlled temporally and spatially during skeletal tissue development and produces complex stimulatory and inhibitory changes in osteoblast functions </plain></SENT>
<SENT sid="8" pm="."><plain>We hypothesise that in vitro differences between <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> osteoblasts may be correlated to different transforming growth factor-beta(1) cascade patterns, probably due to an altered balance between transforming growth factor-beta(1) and basic fibroblast growth factor </plain></SENT>
</text></document>